Phreesia Announces Fiscal Second Quarter 2020 Earnings Conference Call
NEW YORK, Aug. 19, 2019 /PRNewswire/ -- Phreesia, Inc. (NYSE: PHR) ("Phreesia") will hold a conference call on Tuesday, September 10, 2019, at 8:30 a.m. Eastern Time to review the Company's fiscal second quarter 2020 financial results. A press release announcing the fiscal second quarter financial results will be issued after the close of market trading on Monday, September 9, 2019.
To participate in the company's live conference call and webcast, please dial (866) 211-4557 ((647) 689-6750 for international participants) using conference code number 9796424, or visit the "Events & Presentations" section of ir.phreesia.com.
ABOUT PHREESIA Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care.
Investors: Balaji Gandhi Phreesia, Inc. [email protected] (929) 506-4950
Media: Maureen McKinney Phreesia Inc. [email protected] 773-330-8908
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
Participants of this round are:
Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...
